Company Urovant Sciences Ltd.
Equities
UROV
BMG9381B1081
Biotechnology & Medical Research
Business Summary
Number of employees: 70
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 54 | 28/02/19 |
Ajay Bansal
DFI | Director of Finance/CFO | 62 | 27/10/19 |
Chief Tech/Sci/R&D Officer | 66 | - | |
Ryan Kubota
IRC | Investor Relations Contact | - | - |
Kenton Stewart
SAM | Sales & Marketing | - | 01/06/20 |
Nori Ebersole
HRO | Human Resources Officer | 60 | 30/11/17 |
Walt Johnston
PRN | Corporate Officer/Principal | - | 01/06/20 |
Christine Ocampo
AUD | Comptroller/Controller/Auditor | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Hindman
BRD | Director/Board Member | 63 | 19/05/20 |
Sef P. Kurstjens
BRD | Director/Board Member | 60 | 30/06/18 |
James Robinson
CEO | Chief Executive Officer | 54 | 28/02/19 |
Director/Board Member | 59 | 26/12/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,743,396 | 5,633,501 ( 17.20 %) | 0 | 17.20 % |
Company contact information
Urovant Sciences Ltd.
11-12 Saint James's Square Suite 1
SW1Y 4LB, London
+
Sector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |